Chemed Corporation $CHE Stock Holdings Lowered by Harel Insurance Investments & Financial Services Ltd.

Harel Insurance Investments & Financial Services Ltd. lessened its position in Chemed Corporation (NYSE:CHE) by 24.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,374 shares of the company’s stock after selling 3,028 shares during the period. Harel Insurance Investments & Financial Services Ltd. owned approximately 0.06% of Chemed worth $4,192,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CHE. Acadian Asset Management LLC increased its stake in shares of Chemed by 69.3% in the second quarter. Acadian Asset Management LLC now owns 250,722 shares of the company’s stock valued at $122,056,000 after purchasing an additional 102,597 shares during the period. Boston Trust Walden Corp grew its holdings in Chemed by 0.4% in the 2nd quarter. Boston Trust Walden Corp now owns 247,434 shares of the company’s stock worth $120,483,000 after buying an additional 1,083 shares in the last quarter. AQR Capital Management LLC increased its position in Chemed by 160.9% in the 2nd quarter. AQR Capital Management LLC now owns 201,041 shares of the company’s stock valued at $97,893,000 after acquiring an additional 123,982 shares during the period. Norges Bank bought a new stake in Chemed during the 2nd quarter valued at $89,388,000. Finally, DekaBank Deutsche Girozentrale boosted its position in Chemed by 0.4% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 155,267 shares of the company’s stock worth $75,604,000 after acquiring an additional 688 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of research analyst reports. Royal Bank Of Canada lowered their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $574.25.

Chemed Stock Down 1.4%

Shares of Chemed stock opened at $452.40 on Friday. The business has a fifty day simple moving average of $435.69 and a 200-day simple moving average of $444.04. The firm has a market cap of $6.41 billion, a price-to-earnings ratio of 23.92, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing the consensus estimate of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The business had revenue of $624.90 million during the quarter, compared to the consensus estimate of $626.04 million. During the same quarter last year, the firm posted $5.64 earnings per share. Chemed’s revenue was up 3.1% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 17th were given a $0.60 dividend. The ex-dividend date was Monday, November 17th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is 12.69%.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $437.55, for a total value of $875,100.00. Following the transaction, the chief executive officer owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. This represents a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 3.29% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.